Dr Chen Hua Chien, chief executive officer at ACT Genomics, at the new Hong Kong laboratory at the science park in Sha Tin. Photo: Dickson Lee

Hong Kong’s cancer DNA tests industry gets a boost as Taiwanese provider ACT Genomics opens lab

  • Taiwan-based ACT Genomics opens a HK$20 million laboratory at the Science Park in Sha Tin to process cancer patients’ samples
  • The five-year-old firm, based in Taipei, aims to build a regional network of self-operated and joint venture labs
Topic |   Pharmaceuticals

TOP PICKS

Dr Chen Hua Chien, chief executive officer at ACT Genomics, at the new Hong Kong laboratory at the science park in Sha Tin. Photo: Dickson Lee
READ FULL ARTICLE
Eric Ng

Eric Ng

Eric joined the SCMP in 1998 after brief stints in a trading company and translation and editing roles at Dow Jones and Edinburgh Financial Publishing. He has close to 20 years of experience covering China's energy, mining and industrial materials sectors, and has recently added biotechnology to his coverage. Eric has a Masters of Business Administration degree.